Funding Will Support the Company’s First Clinical Trial on its Path to Regulatory Clearance OR YEHUDA, Israel, Aug. 4, 2021 /PRNewswire/ — Append Medical, developer of the first no-implant minimally invasive solution for transcatheter Left Atrial Appendage (LAA) exclusion, today announced the completion of a $7.4 million Series A financing round. The round will enable Append […]